Clinical Trials Directory

Trials / Sponsors / Vitreous -Retina- Macula Consultants of New York

Vitreous -Retina- Macula Consultants of New York

Academic / Other · 11 registered clinical trials.

StatusTrialPhaseStarted
UnknownIntense Treatment Regimen With Intravitreal Aflibercept Injection
Neovascular Age-Related Macular Degeneration
Phase 1 / Phase 22018-09-11
CompletedTo Evaluate The Role of Intravitreal Aflibercept Injection (2.0 mg) in the Management of Previously Treated Pa
AMD (With Persistent or Recurrent Fluid Despite Monthly Intravitreal Anti-VEGF Therapy)
Phase 42011-12-01
WithdrawnOpen Label to Study to Evaluate Effect of Alfilbercept on Patients With (FVPED) Fibrovascular Pigment Epitheli
Fibrovascular Pigment Epithelial Detachment
Phase 42011-12-01
CompletedA Pilot Study to Evaluate the Role of High-dose Ranibizumab (2.0mg) in the Management of AMD in Patients With
Age Related Macular Degeneration
Phase 1 / Phase 22010-05-01
WithdrawnStudy of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneratio
Age Related Macular Degeneration, AMD, CNV
Phase 12008-03-01
WithdrawnSecond Line Therapy to Treat Age-related Macular Degeneration (AMD) for Patients Not Responding Well to Lucent
Age Related Macular Degeneration
Phase 22007-01-01
WithdrawnImatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Seco
Choroidal Neovascularization
Phase 12006-11-01
CompletedIntravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema
Retinal Vein Occlusion
Phase 12006-11-01
TerminatedBevacizumab in Combination With Verteporfin Reduced and Standard Fluence in the Treatment of Hemorrhaged Lesio
Macular Degeneration
Phase 12006-09-01
CompletedIntravitreal Ranibizumab Treatment of Central Serous Chorioretinopathy
Central Serous Chorioretinopathy
Phase 12006-08-01
No Longer AvailableUse of Eylea for the Treatment of an Optic Nerve Hemangioma
Retinal Hemangioma
——